|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 83.85 USD | +0.14% |
|
-0.02% | +80.13% |
| 07-08 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
| 07-07 | IBT company Crinetics to be acquired by Vertex for USD10 billion | AN |
| Market Cap | 8.84B 7.77B 7.23B 6.64B 12.48B 848B 12.64B 86B 33.59B 419B 33.19B 32.47B 1,447B | P/E 2026 * |
-17.8x | P/E 2027 * | -20.1x |
|---|---|---|---|---|---|
| Enterprise Value | 7.81B 6.86B 6.39B 5.87B 11.02B 749B 11.16B 75.93B 29.66B 370B 29.3B 28.67B 1,278B | EV / Sales 2026 * |
114x | EV / Sales 2027 * | 46.3x |
| Free-Float |
98.21% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Crinetics Pharmaceuticals, Inc.
| 1 day | +0.14% | ||
| 1 week | -0.02% | ||
| Current month | +124.08% | ||
| 1 month | +128.47% | ||
| 3 months | +117.12% | ||
| 6 months | +58.31% | ||
| Current year | +80.13% |
| 1 week | 83.64 |  | 84 |
| 1 month | 35.74 | | 84 |
| Current year | 32.3 | | 84 |
| 1 year | 25.83 | | 84 |
| 3 years | 15.76 | | 84 |
| 5 years | 15.23 | | 84 |
| 10 years | 10.63 | | 84 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Betz
CTO | Chief Tech/Sci/R&D Officer | 60 | 2021-09-30 |
R. Struthers
CEO | Chief Executive Officer | 64 | 2008-11-30 |
Tobin Schilke
DFI | Director of Finance/CFO | 51 | 2025-02-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Wendell Wierenga
CHM | Chairman | 78 | 2015-09-30 |
R. Struthers
BRD | Director/Board Member | 64 | 2008-10-31 |
Matthew Fust
BRD | Director/Board Member | 61 | 2018-01-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/2/26 | Sell | Director | -3,000 | 0.0028% | ||
| 6/18/26 | Free | Director | 15,655 | 0.0148% | ||
| 6/18/26 | Free | Chairman | 15,655 | 0.0148% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.14% | -0.02% | +170.57% | +354.23% | 8.83B | |
| -1.82% | +4.80% | +56.71% | +68.36% | 57.28B | |
| -0.27% | +0.35% | +40.26% | +79.88% | 54.99B | |
| -2.05% | -2.14% | +0.75% | +413.38% | 23.18B | |
| +1.97% | -1.16% | -21.00% | -13.25% | 22.59B | |
| +0.05% | -0.21% | +21.06% | -10.53% | 20.46B | |
| +1.57% | +3.30% | +28.01% | -29.07% | 17.56B | |
| +0.39% | +0.78% | +34.95% | +559.63% | 15.67B | |
| +5.29% | +1.70% | +185.09% | +333.94% | 14.46B | |
| +0.79% | +0.50% | +22.39% | +184.74% | 13.92B | |
| Average | +0.62% | +1.35% | +53.88% | +194.13% | 24.89B | |
| Weighted average by Cap. | +0.02% | +1.47% | +44.07% | +145.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 68.49M 60.21M 56.05M 51.47M 96.66M 6.57B 97.93M 666M 260M 3.24B 257M 252M 11.21B | 172M 151M 141M 129M 243M 16.51B 246M 1.67B 654M 8.15B 646M 632M 28.18B |
| Net income | -516M -454M -423M -388M -729M -49.53B -738M -5.02B -1.96B -24.46B -1.94B -1.9B -84.53B | -473M -415M -387M -355M -667M -45.32B -676M -4.6B -1.8B -22.38B -1.77B -1.74B -77.35B |
| Net Debt | -1.04B -910M -847M -778M -1.46B -99.26B -1.48B -10.07B -3.93B -49.01B -3.89B -3.8B -169B | -865M -761M -708M -650M -1.22B -82.97B -1.24B -8.42B -3.29B -40.97B -3.25B -3.18B -142B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-27 | US$83.85 | +0.14% | 5,216,886 |
| 26-07-24 | US$83.73 | +0.10% | 2,344,336 |
| 26-07-23 | US$83.65 | -0.08% | 4,268,877 |
| 26-07-22 | US$83.72 | -0.21% | 4,935,041 |
| 26-07-21 | US$83.90 | +0.04% | 2,734,950 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CRNX Stock
Select your edition
All financial news and data tailored to specific country editions
